ArticleClinical cancer research : an official journal of the American Association for Cancer Research2025

FDA Approval Summary: Axatilimab for Adult and Pediatric Patients Weighing at Least 40 Kilograms with Chronic GVHD after Two Prior Lines of Systemic Therapy.

Robert Q Le et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.